Pancreatic Cancer Research

ResearcherCity of HopeActive in the last 2 years

Zhenyu Dai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1856-5061; OpenAlex author ID A5101436076. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Off-the-shelf invariant NKT cells expressing anti-PSCA CAR and IL-15 promote pancreatic cancer regression in mice. Co-author DOI 10.1172/jci179014↗
  2. B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.814312↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianhua Yu · 2 shared papers, 2022–2025 · strength 0.35
  2. Kun‐Yu Teng · 2 shared papers, 2022–2025 · strength 0.35
  3. Li-Shu Wang · 1 shared paper, 2025 · strength 0.24
  4. Laleh Golkar Melstrom · 1 shared paper, 2025 · strength 0.24
  5. Michael A. Caligiuri · 1 shared paper, 2025 · strength 0.24
  6. Dechun Li · 1 shared paper, 2022 · strength 0.11
  7. Xin Zhao · 1 shared paper, 2022 · strength 0.11
  8. Songbing He · 1 shared paper, 2022 · strength 0.11
  9. Zheng Gang Zhu · 1 shared paper, 2022 · strength 0.11
  10. Yunyun Xu · 1 shared paper, 2022 · strength 0.11
  11. Vincent M. Chung · 1 shared paper, 2022 · strength 0.11
  12. Jian Zhou · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.